Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Buildings: 2016-2017

  • Aytu Biopharma's Buildings rose 537.78% to $287,000 in Q2 2017 from the same period last year, while for Jun 2017 it was $287,000, marking a year-over-year increase of 537.78%. This contributed to the annual value of $287,000 for FY2017, which is 537.78% up from last year.
  • Per Aytu Biopharma's latest filing, its Buildings stood at $287,000 for Q2 2017, which was up 537.78% from $45,000 recorded in Q2 2016.
  • Aytu Biopharma's Buildings' 5-year high stood at $287,000 during Q2 2017, with a 5-year trough of $45,000 in Q2 2016.
  • Over the past 2 years, Aytu Biopharma's median Buildings value was $166,000 (recorded in 2016), while the average stood at $166,000.
  • Data for Aytu Biopharma's Buildings shows a peak YoY surged of 537.78% (in 2017) over the last 5 years.
  • Quarterly analysis of 2 years shows Aytu Biopharma's Buildings stood at $45,000 in 2016, then soared by 537.78% to $287,000 in 2017.